BFC Planning’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Other funds holding FULC
BFC Planning's FULC Position: Q3 2026 in Review
BFC Planning opened a new position in Fulcrum Therapeutics (FULC) in Q3 2026: 200 shares worth $740. The stake represents ﹤0.01% of the portfolio and ranks #3230 among its holdings.
97 funds tracked by Wall St. Rank hold FULC as of Q3 2026.
- BFC Planning held 200 shares of Fulcrum Therapeutics worth $740 as of Q3 2026.
- Fulcrum Therapeutics was a new BFC Planning position in Q3 2026.
- Fulcrum Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3230 holding.
- 97 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.